David Altshuler
David Altshuler is the chief scientific officer of Vertex Pharmaceuticals, where he has been instrumental in the development of new pain medications, including the innovative non-opioid painkiller Journavx. His work focuses on targeting specific channels in pain-sensing neurons to reduce pain without the risk of addiction.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 7.00 | 0.04% | +0% | 67,886,011 | 24,677 | $2,700,000 | 981$ |
| Totals | 1 | 67,886,011 | 24,677 | $2,700,000 | 981$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
David Altshuler is the chief scientific officer of Vertex Pharmaceuticals.
7